Concord Biotech (BOM:543960) YoY EBITDA Growth : 38.62% (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Concord Biotech's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 38.62%.

Concord Biotech's EBITDA per Share for the three months ended in Mar. 2025 was ₹18.93.

Concord Biotech YoY EBITDA Growth Historical Data

The historical data trend for Concord Biotech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech YoY EBITDA Growth Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

YoY EBITDA Growth

Get a 7-Day Free Trial

44.71

-14.04

29.86

23.16

17.22

Concord Biotech Quarterly Data
	Mar20	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial									2.59	9.63	16.12	-2.14	38.62

Concord Biotech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Concord Biotech's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (A: Mar. 2025 )
=	(EBITDA per Share (A: Mar. 2025 )	-	EBITDA per Share (A: Mar. 2024 ))	/	\| EBITDA per Share (A: Mar. 2024 ) \|
=	(52.515	-	44.801)	/	\| 44.801 \|
=	17.22 %

Concord Biotech's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(18.929	-	13.655)	/	\| 13.655 \|
=	38.62 %

Concord Biotech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Concord Biotech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines